Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs
Drug Metabolism and Disposition · 2026-10 · 54 (10) · 100385
DOI: 10.1016/j.dmd.2026.100385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-10. Verfasst von Griffin D Shaffer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pharmacology, Phy…. Hauptthemen laut MEDLINE: Proteomics, Phosphotransferases. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cincinnati Children's Hospital Medical Center, Washington State University.
Abstract (Originalsprache)
Kinases catalyze the activation of certain nucleoside and nucleotide analog drugs used in the treatment of various cancers and viral infections. Because these drugs require intracellular phosphorylation to their active form, the abundance of kinases within tissues is a key factor in determining both variability in response and off-target effects. In this study, we quantified and compared protein abundances of kinases in commercially available pooled S9 fractions of adult human liver (n = 50), kidney (n = 12), lung (n = 5), intestine (n = 4), and individual adult primary hepatocytes (n = 8). These data were compared with the proteomic abundance profile of red blood cells (n = 4) from healthy donors and bone marrow samples (n = 44) from patients with acute myeloid leukemia, in addition to kinase abundance in human plasma from the publicly available data base Human Protein Atlas. Kinase protein abundance was estimated using the total protein approach in pmol/mg total protein. We detected 364 kinases, including 23 drug-metabolizing kinases, with varying abundances across tissue and biofluid types. Four drug-metabolizing kinases, adenosine kinase, cytidine/uridine monophosphate kinase 1, and nucleoside diphosphate kinases 1 and 3, were detected in all sample types. In addition, by comparing tissue-to-plasma abundance ratios of kinases with those of known secreted versus nonsecreted marker proteins, we showed that kinases are primarily present in plasma due to tissue shedding, with few (phosphoglycerate kinase 1, pyruvate kinase M, adenylate kinase 1, and nucleoside diphosphate kinase 1) that may be present as part of extracellular vesicles. Lastly, we identified the presence of 24 kinases commonly targeted by inhibitors across sample types. Overall, this study advances the understanding of the presence and variability of kinases in different tissues. SIGNIFICANCE STATEMENT: This study quantified and compared the presence and abundance of kinases, including drug-metabolizing kinases, across various human sample types. In total, 364 kinases, including 23 known drug-metabolizing kinases, were detected with varying abundances across tissue and biofluid types. This study provides important quantitative data about drug-metabolizing kinases that can be used to understand variability in response and the off-target effects of nucleoside analog drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicin…
- Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. Electronic address: Bhagwat.Pra…
Förderung
- Cincinnati Children's Hospital Medical Center
- Washington State University
Zitieren
APA
Shaffer, G. D., Singh, D. K., Subash, S., & Prasad, B. (2026). Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs. Drug Metabolism and Disposition, 54(10), 100385. https://doi.org/10.1016/j.dmd.2026.100385
Vancouver
Shaffer GD, Singh DK, Subash S, Prasad B. Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs. Drug Metabolism and Disposition. 2026;54(10):100385. doi:10.1016/j.dmd.2026.100385
BibTeX
@article{Shaffer2026,
author = {Shaffer, Griffin D and Singh, Dilip Kumar and Subash, Sandhya and Prasad, Bhagwat},
title = {Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {10},
pages = {100385},
doi = {10.1016/j.dmd.2026.100385}
}
EUVIMED